Autologous anti-KRAS G12V mTCR gene-engineered cell therapy (National Cancer Institute)

N/A

ๆŠฅๅ‘Šๆ—ถ้—ด: 2024/02/10 20:00:40

ๅŸบๆœฌไฟกๆฏ

่ฏ็‰ฉๅ็งฐAutologous anti-KRAS G12V mTCR gene-engineered cell therapy (National Cancer Institute)
่ฏ็‰ฉๅˆซ็งฐanti-KRAS G12V mTCRanti-KRAS G12V/HLA-A*1101 TCR T-cell therapy (National Cancer Institute)
่ฏ็‰ฉ็ฑปๅž‹็ป†่ƒžไธŽๅŸบๅ› ็–—ๆณ• > ็ป†่ƒž็–—ๆณ• > ๅ…็–ซ็ป†่ƒž็–—ๆณ• > ๆท‹ๅทด็ป†่ƒž็–—ๆณ• > T็ป†่ƒž็–—ๆณ• > TCR็ป†่ƒž็–—ๆณ•็ป†่ƒžไธŽๅŸบๅ› ็–—ๆณ• > ็ป†่ƒž็–—ๆณ• > ไพ›ไฝ“ > ่‡ชไฝ“็ป†่ƒžไธŽๅŸบๅ› ็–—ๆณ• > ็ป†่ƒž็–—ๆณ• > ็ป†่ƒžๆฅๆบ > ๅค–ๅ‘จ่ก€ๆฅๆบ +[4]ย 
ไฝœ็”จๆœบๅˆถKRAS G12V่ฐƒ่Š‚ๅ‰‚
้ถ็‚นKRAS G12V
ๆฒป็–—้ข†ๅŸŸ / ้€‚ๅบ”็—‡่ƒฐ่…บ็™Œ่ƒƒ็™Œ็›ด่‚ ็™Œ +[5]ย 
ๅ…จ็ƒๆ‰นๅ‡†้€‚ๅบ”็—‡N/A
ไธญๅ›ฝๆ‰นๅ‡†้€‚ๅบ”็—‡N/A
้ฆ–ๆ‰นๅ›ฝๅฎถ/ๅŒบๅŸŸN/A
้ฆ–ๆ‰นๆ—ฅๆœŸN/A
ๅ›ฝๅฎถ/ๅŒบๅŸŸ็พŽๅ›ฝ
ๆ˜ฏๅฆๅคๆ–นๅฆ
ๅ…จ็ƒๆœ€้ซ˜็ ”ๅ‘็Šถๆ€ไธดๅบŠไบŒๆœŸ
ไธญๅ›ฝๆœ€้ซ˜็ ”ๅ‘็Šถๆ€N/A
ๅŽŸ็ ”ๅ…ฌๅธ็พŽๅ›ฝๅ›ฝ็ซ‹็™Œ็—‡็ ”็ฉถๆ‰€
ๆณจๅ†Œๅˆ†็ฑปN/A

็ ”ๅ‘ไฟกๆฏ

ๆดป่ทƒๅ…ฌๅธ็พŽๅ›ฝๅ›ฝ็ซ‹็™Œ็—‡็ ”็ฉถๆ‰€
้žๆดป่ทƒๅ…ฌๅธN/A
ๆดป่ทƒ้€‚ๅบ”็—‡่ƒฐ่…บ็™Œ่ƒƒ็™Œ็›ด่‚ ็™Œ +[5]ย 
้žๆดป่ทƒ้€‚ๅบ”็—‡N/A

ๅ…ถไป–ไฟกๆฏ

ATCไปฃ็ N/A
็›ธๅ…ณ้“พๆŽฅN/A